Washington, DC Healthcare Practice Acquisition and Startup Financing

If you already know your lane, use the link that matches it: a buyout, a de novo startup, or an expansion. If you are still sorting that out, start with practice acquisition financing for purchase deals and keep the acquisition financing hub open when you need the broader map across startup, acquisition, and growth capital.

What to know

Washington, District of Columbia does not change the underwriting math much. Lenders still want the same three answers: can the practice service the debt, how much equity are you bringing, and what collateral or cash flow backs the loan. The difference is in the deal structure. A buyer of an established dental, veterinary, or physician practice is financing goodwill, charts, equipment, and sometimes real estate. A startup is financing buildout, equipment, payroll, and enough working capital to survive the first slow months. Expansion sits in between: you may already have revenue, but you still need room for hiring, tenant improvements, or new gear. That is why the same borrower can land on a very different product depending on whether the money is for an acquisition, startup, or working capital.

Situation	Usually fits	What trips people up
Acquisition	Existing patient base, seller transition, goodwill, and equipment	Weak valuation, thin cash flow, or too little equity
Startup	New office, new specialty, or de novo location	No trailing revenue and underbudgeted working capital
Expansion	Add a location, hire clinicians, or buy new equipment	Borrowing against projections that are too optimistic

For many buyers, the practical split is simple. If you are buying an operating practice, the lender is reviewing the deal like a cash-flow asset, not just a piece of equipment. That is where medical practice valuation for lending, seller notes, and debt service coverage matter. If you are opening from scratch, the file starts looking more like a capital stack: buildout, equipment, leasehold improvements, payroll, and a buffer for slower collections. And if the need is narrower, such as a chair, scanner, or lab setup, medical practice equipment leasing can be cleaner than funding the whole practice through one term loan.

The numbers that usually separate the options are straightforward. For SBA 7(a), lenders commonly look for 640+ FICO, 24 months in business, 1.25x DSCR, and 12 months of bank statements. That profile is common for bank loans for private practice owners who already have operating history. Bigger deals can still fit under SBA 7(a) up to $5 million, but the approval still comes down to whether the practice can carry the payment. In most cases, that means clean books, a defensible valuation, and a borrower who can explain how the practice will absorb new debt without starving operations.

Equipment-only capital moves faster. Strong-credit borrowers often see 1 to 3 days for approval, with 10% to 20% down and about 8% to 11% APR for 2026. That speed is useful when the bottleneck is a machine purchase, not a full acquisition package. For startup working capital, the math is harsher because there is no trailing revenue to point to yet, so lenders usually want more cash in the deal and a tighter plan for how the first 6 to 12 months will be funded. If your DC launch is inventory-heavy or payroll-heavy, the same working-capital logic shows up in other regulated practices too, including DC medical aesthetics inventory financing, where lenders focus on cash gaps, supply timing, and early operating runway.

Use the leaf guide that matches the true use of funds. A purchase deal, a startup, and an expansion may look similar on paper, but the underwriting is not the same.